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ABSTRACT
Objectives: To investigate the patient’s experience of
the trajectory to receiving a diagnosis of pulmonary
arterial hypertension (PAH) and inform the provision of
care for this patient group.
Design: Qualitative study using in-depth one-to-one
interviews and pictorial representations. Data were
analysed using thematic analysis.
Setting: Participants were interviewed in their own
homes across England.
Participants: 30 patients with a diagnosis of
pulmonary hypertension (18 participants were women,
mean age 56 and range 26-80 years and time since
diagnosis ranged from a few months to more than
12 years) participated.
Results: All participants, regardless of the time since
diagnosis, vividly described the process from
manifestation of symptoms to receiving a conﬁrmed
diagnosis. The authors present data using three major
themes: (i) making sense of symptoms, (ii) process of
elimination and (iii) being diagnosed with PAH. Making
sense of symptoms represented an early period of
perseverancedpeople tried to carry-on as usual
despite ‘unexplained breathlessness’. As time
progressed, this period was punctuated by critical
events that triggered seeking medical advice. Once
medical contact had been made, patients described
a period of ‘elimination’ and convoluted contact with
the medical profession. Dyspnoea misdiagnosis was
a key factor that delayed the PAH diagnosis. Diagnosis
disclosure by some medical professionals was also
viewed as lacking empathy. More positive experiences
were relayed when the medical team disclosing the
diagnosis acknowledged previous limitations.
Conclusions: A lack of awareness of this illness from
both the sufferer themselves and the medical
profession emerged as a central theme and led to
prolonged periods of being misdiagnosed. The
application of a diagnostic pathway for unexplained
dyspnoea that alerts practitioners to rare conditions
could expedite the process of correct diagnosis.
INTRODUCTION
Pulmonary arterial hypertension (PAH) is
a rare life-limiting disease that can progress
rapidly. Living with a life-limiting illness can
present many challenges. Only two studies
have previously investigated the experience
of living with PAH from the patient’s
perspective; both reported the challenge of
coping with uncertainty and living with inva-
sive treatment regimens.
1 2 With the avail-
ability of effective therapy, early disease
detection is an important strategic objective
to improve patient outcomes.
3 PAH can be
idiopathic, familial or associated with
a number of conditions such as portal
hypertension, connective tissue disease or
exposure to drugs and toxins.
4 This can make
the process of diagnosing PAH challenging.
There is speculation that PAH may not be
as rare as reported, but rather it is under
diagnosed.
5 Patients with PAH generally
present with a spectrum of symptoms that
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ARTICLE SUMMARY
Research questions
- What is the patient’s experience to receiving
a diagnosis of pulmonary hypertension?
- What are the key patient and healthcare profes-
sional factors that prolong diagnosis?
Key messages
- There is a lack of awareness of this illness from
both the sufferer themselves and the medical
profession.
- A diagnostic pathway for unexplained dyspnoea
may assist professionals to increase initial
suspicion that less known conditions, such as
PAH, may be present.
- The pre-diagnostic journey can have long lasting
effects on the individual and should form part of
the patient’s care pathway following referral to
the specialist PAH centre.
Strengths and limitations of this study
- This is the ﬁrst study to explore the PAH pre-
diagnostic journey. Data were collected using in-
depth interviews incorporated with a novel
approach of collecting pictorial representations.
Given the role that medical professionals play in
the patients’ trajectory to diagnosis, their inclu-
sion would be warranted in future studies.
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Open Access Researchmay be attributed to general deconditioning or other
cardiopulmonary conditions. Exertional dyspnoea is the
most frequent presenting symptom, present in approxi-
mately 60% of patients and is eventually present in
virtually all patients as the disease progresses.
6 Fatigue
and general exertion intolerance are also common
complaints. Assessment of PAH is based on a logical
sequence of determining whether there is a risk of PAH
being present, whether PAH is likely to be present based
on initial non-invasive evaluation and clarifying the
underlying aetiology of PAH in an individual patient.
7
Unfamiliarity with the condition by the general public
and medical profession delays initial suspicion that PAH
is likely to be present.
On average, the time period between the onset of the
ﬁrst symptoms to conﬁrmed diagnosis of PAH ranges
from 1 to 4 years.
8 9 Patient delay is most notably due to
dyspnoea on exertion that is often attributed to decon-
ditioning.
8 Typically, patients are often seen by
numerous doctors and receive incorrect diagnoses
before a conﬁrmed diagnosis of PAH is made. A survey
conducted in the UK (N¼488) showed that healthcare
professional delay possesses a signiﬁcant challenge: 44%
of respondents were reviewed by four or more doctors
before being correctly diagnosed and over a third
experienced a delay of two or more years between seeing
a doctor for the ﬁrst time and being diagnosed.
9
Reasons for patient and professional diagnostic delay
in PAH are poorly understood. Anderson’s model of
Total Patient Delay
10 provides detailed stages of
a patient’s pre-diagnostic pathway from awareness of a
symptom to diagnosis and treatment. The model stipu-
lates that people experience a series of stages, each
governed by a conceptually distinct set of decisional and
appraisal processes. The model has been applied to gain
a greater understanding of delayed diagnosis of different
types of cancer.
11e13 In this study, we applied Anderson’s
model as a conceptual guide to understanding the
trajectory to diagnosis with PAH. There are likely to be
psychological consequences for patients and their fami-
lies as a result of delayed diagnosis and access to
appropriate services and support. The pre-diagnostic
moments on the illness trajectory were important to
people with cancer and inﬂuenced levels of satisfaction
with subsequent care.
14
This paper reports the data obtained from
a programme of research exploring the experience of
living with PAH. The focus of this report is the trajectory
from symptoms ﬁrst manifesting to receiving
a conﬁrmed diagnosis of PAH.
METHODS
Given the paucity of research and exploratory nature of
the enquiry, a qualitative research approach was
adopted. In-depth semistructured interviews were
utilised to capitalise on the intricacies of the experiences
of the participants. A semistructured interview style
provides the ﬂexibility to ensure that key topics are
covered while enabling the interviewee to disclose
information that may diverge from the interview guide.
The aim of the interviews was to explore participants’
experiences of living with this rare condition.
Throughout the interviews, it became apparent that the
pre-diagnostic phase represented a turbulent and
poignant period for participants. This was also evident in
the pictorial representations where participants focused
largely on their experiences during the pre-diagnostic
period. This was an unexpected ﬁnding. The decision
was made to extract data that reﬂected the trajectory to
receiving a conﬁrmed PAH diagnosis and is presented in
this paper.
Participants
Participants were recruited from the Pulmonary Hyper-
tension Association UK database. The Pulmonary
Hypertension Association is the only charity in the UK
especially for people with pulmonary hypertension with
approximately 3000 members. Members attending the
2009 PHA UK annual conference were informed about
the project, and contact details were collected from
those who expressed an interest in participating. We
purposively sampled from this list to ensure maximal
variation including both men and women with different
ages, a range of aetiologies and time since diagnosis and
different geographical areas in England. The study
interviews were conducted in 2010 and took place in the
patient’s home. Thirty one-to-one in-depth interviews
were conducted with patients with PAH. Details of the 30
patients are provided in table 1. Informed written
consent was obtained from all participants at the
beginning of the study and reviewed verbally at the time
of interview. All participants provided informed written
consent. Ethical approval was obtained from the
Pulmonary Hypertension Association Medical
Committee (01-2011) and the University of Salford
Ethical Committee (NURA018).
Data collection and analysis
The in-depth interview guide was designed to cover the
patient’s experience of living with PAH (see box 1 for
topic areas). Interviews were conducted by an experi-
enced health researcher (SB) in participant’s homes,
and each lasted between 40 and 100 min. At the begin-
ning of the interview, participants were also asked to
map put their ‘individual journey’ using a pictorial
representation that included a straight line anchored
with the words ‘Before I had PAH’ and ‘Now’. This
approach afforded participants with the opportunity to
frame their own experiences.
15 16 In this current study,
the drawing technique was presented to participants as
a timeline to assist participants to organise information
and analyse the impact of previous experiences on
current life.
17 Interviews were audio-recorded and tran-
scribed verbatim.
The method of thematic analysis described by Braun
and Clarke
18 was used to analyse the data collected. This
method was employed to enable a ﬂexible approach for
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data. In addition, participants tended to tell their stories
chronologically and thematic analysis enabled themes
that represented key milestones in the trajectory from
pre-PAH to post-PAH diagnosis to form the basis of the
data reported in this paper. Data analysis was conducted
by NR and SB and JY conducted a review of the audit
trail to conﬁrm validity of the themes extracted.
RESULTS
The characteristics of the 30 patients recruited to the
study are detailed in table 1. The coding used to repre-
sent participants is as follows: P ¼ participant; F ¼
female, M ¼ male; individual study code; participant’s
age (eg, PF2:56 is a female patient, study code 2 and
56 years of age).
All participants, regardless of the time since diagnosis,
vividly described the process from initially experiencing
subtle symptoms to receiving a conﬁrmed diagnosis of
PAH, both verbally and via a pictorial representation.
Participants seemed to have a ‘need’ to recount their
pre-diagnostic journey, and it was from this that the data
set of the patient’s pre-diagnosis journey was extracted.
Due to the length of time it took for an eventual diag-
nosis, the plethora of medical consultations and tests
and consequent emotional roller coaster, the road to
diagnosis was strewn with feelings of ‘frustration’, ‘anger’
and ‘uncertainty’ for both the patient and their family.
This is illustrated in the pictorial representationsdthese
tended to focus mostly on the pre-diagnostic period as
opposed to post-diagnosis (ﬁgures 1 and 2). We present
data using three major themes that represent the chro-
nological stories relayed by participants: (i) making
sense of the symptoms, (ii) the process of elimination
and (iii) being diagnosed with PAH: ‘It’s worse than
cancer; we can’t treat it’.
Research participants were requested to use the paper
and drawing utensils to map out their journey on the
timeline from ‘Before I had PH’ to ‘Now’. The partici-
pants were provided with a range of resources including
stickers that represented a range of facial expressions
and emotions and different clinical tests. Information
placed above the timeline was described as representing
‘good’ experiences and information placed below as
representing ‘bad’ experiences.
Symptom appraisal
Explanations considered accounting for the symptoms
experienced
Many participants did not visit a doctor until they had
symptoms for over a year. Participants were able to
provide detailed descriptions of symptoms that were
experienced for extended periods of time including
breathlessness, palpitations, chest pain, haemoptysis and
oedema and associated weight gain, all known to be
associated with PAH.
4 5 A process of appraising the
presence and cause of symptoms was apparent (Ander-
son’s stage 1, see ﬁgure 3). Although generally
acknowledged as ‘gradually creeping on’, breathlessness
was salient though meant many different things: ‘just
getting unﬁt’ [PF2:56; PF26:52], ‘getting old’ [PM08:70]
and ‘I’ve always had . things like ﬂu’ [PF19:34].
Participants who had recently given up smoking around
Table 1 Characteristics of the 30 patients with pulmonary
arterial hypertension interviewed for the study
Number of
patients (N[30)
Sex (female:male) 18:12
Age (mean years (SD, range)) 56.3 (38, 2680)
Working status
Work full time 2
Work part time 4
Retired 11
Long-term sick 9
Unemployed 2
Education full time 1
Education part time 1
PAH aetiology
Idiopathic 11
Connective tissue disease 7
Congenital heart disease 5
Chronic thromboembolic 2
Heritable 1
Portal hypertension 1
Lung disease 1
Drugs/toxins 1
Duration of symptoms prior to
seeking medical advice (mean time)
1 year, 9 months
Time since PAH diagnosis
<1 year 2
1t o<3 years 2
3t o<5 years 7
5t o<10 years 12
>10 years 7
NYHA classiﬁcation
I0
II 9
III 19
IV 2
PAH, pulmonary arterial hypertension.
Box 1 Interview guide pertinent to this paper
- Participants were asked to map out their journey showing
all the highs and lows, and the key events along the way,
via pictorial representations. A range of stimulus mate-
rials were provided (ﬁgures 1 and 2).
- Participants were encouraged to discuss their journey
while completing their picture.
- The following questions relevant to this paper were
asked:
– When you were ﬁrst diagnosed what were your
thoughts and feelings?
– How do you feel about pulmonary hypertension now?
– In what ways, if any, have your perceptions regarding
pulmonary hypertension changed since you were ﬁrst
diagnosed?
Armstrong I, Rochnia N, Harries C, et al. BMJ Open 2012;2:e000806. doi:10.1136/bmjopen-2011-000806 3
The trajectory to diagnosis with pulmonary hypertensionthe same time as experiencing symptoms ‘just assumed
that everything was down to smoking’ [PF26:52] and that
‘people get short of breath once they give up smoking’
[PF19:34].
A period of perseverance was described by participants
as they attempted to rectify their perceived lack of
ﬁtness. Younger participants in particular told stories of
taking unknown risks and ‘just carried on regardless’
[PF14:35], leading to a delayed process of symptom
interpretation. ‘I was getting really out of breath . on
the step machine or running machine . very quickly,
but couldn’t understand why. I was going down there two
or three times a week . I’m thinking . I should be
getting ﬁtter’ [PF7:35].
Alternatively, some participants used avoidance strate-
gies and adapted activities according to the severity of
the breathlessness they experienced: ‘I was late for the
tram . I decided to run for it. I was astonished to ﬁnd
that as I got onto it, I felt really out of breath and really
ill . it was great shock . I decided; perhaps I won’t run
for the tram in future. At that point I did nothing about
it’ [PM11:63]. The decision to seek medical opinion was
delayed as participants ‘knew something was wrong .
but . didn’t want to’ [PF19:34]. Covering-up of symp-
toms became the norm in an attempt to protect both
oneself and family members: ‘I remember thinkingdI’m
going to have to sort of stop and pretend I’m looking at
trafﬁc’ [PF5:63] and ‘I started to think, this is really bad
. I hid it all the time.’ [PF14:35]. This frequently led to
a delay in time from the person concluding that he or
she had a serious health problem to deciding to seek
professional help (Anderson’s stage 2).
Trigger for seeking medical advice
Perceived seriousness of the physiological condition by
either the patient or a family member was the catalyst
required for medical contact to be made (Anderson’s
stages 3 and 4). All participants recalled the time when
they ﬁrst decided to seek medical advice, and this often
involved a dramatic description where either the patient
themselves or a family member or friend initiated
seeking medical advice (box 2).
Process of elimination
‘They can only eliminate everything else and then it’s got
to be pulmonary hypertension’ [PM25:54].
Figure 1 Research participants were requested to use the paper and drawing utensils to map out their journey on the timeline
from “Before I had PH” to “Now”. The participants were provided with a range of resources including stickers that represented
a range of facial expressions and emotions, and different clinical tests. Information placed above the timeline was described as
representing “good” experiences and information placed below as representing “bad” experiences.
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The ﬁrst visit to the doctor by no means guaranteed
a diagnosis; most participants had to see four or more
doctors before they were correctly diagnosed with PAH.
Any particular symptom could have been due to the
subsequent diagnosis or to some other condition, espe-
cially if months or years had passed between symptom
presentation and diagnosis. All participants went
through a phase of visiting their GP but to no avail: ‘he
[GP] didn’t know what I was talking about. He couldn’t
ﬁnd a thing and I was just getting worse’ [PF20:75]. One
young participant described her “lowest pointdevery-
thing had gone wrong . they [GP’] couldn’t explain
the swelling, my heart rate was incredibly high, I
couldn’t breathe, had low blood pressure.” Misdiagnosis
by the GP and numerous specialists that patients were
referred to was common (box 3).
Throughout the telling of their histories, participants
spoke of how they felt that clinicians ‘didn’t recognise
pulmonary hypertension’ [PM8:80] and had little
understanding of the diagnostic indicators. All partici-
pants described undergoing a battery of tests either
requested by the GP or by one of the numerous
specialists that they were referred to, with many of
the tests being repeated on multiple occasions: ‘He’d
just no idea what it was so he just kept putting me on
Figure 2 Research participants were requested to use the paper and drawing utensils to map out their journey on the timeline
from “Before I had PH” to “Now”. The participants were provided with a range of resources including stickers that represented
a range of facial expressions and emotions, and different clinical tests. Information placed above the timeline was described as
representing “good” experiences and information placed below as representing “bad” experiences.
Figure 3 Anderson’s model of ‘total patient delay’ and its
relationship to pulmonary arterial hypertension.
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end, he said I don’t think we’re getting anywhere’
[PF14:35].
Participants were subsequently referred from one
specialist to another: ‘it was the cardiac specialist, respi-
ratory specialist, Warfarin specialist, radiographer, a case
conference’ [PF29:26]. The lack of explanation or
diagnosis led to feelings of anger and frustration: ‘when
I was sent home I was fuming . when they’re telling you
that there’s nowt [nothing] wrong with you and you
know there is’ [PM3:47]. Participants became ‘disillu-
sioned . [I was thinking] there must be something
wrong and somebody isn’t recognising what it is’
[PM8;80]. Delays or concerns that their symptoms were
not being taken seriously sometimes also prompted
participants to use private healthcare services.
Life interrupted
Given the lack of a medical diagnosis, participants tried
to carry on with family and work life as normal, despite
worsening symptoms. One participant explained how
she would weed her garden lying on the ground because
‘I couldn’t breathe if I bent down’ [PF13:65].
Having no apparent medical reason for being so ill
made working difﬁcult too: ‘work didn’t like itd‘nobody
gets a cold that often’dI was being bullied’ [PF26:56]
and ‘sick notes, I actually had a reputation for being .
a bit . illy [sick] type person. I hated it’ [PF19:34].
Misconceptions from work colleagues who thought ‘well,
you should be better by now’ [PF29:26] also led to
participants trying to hide their symptoms at work.
Being diagnosed with pulmonary hypertension
‘It’s worse than cancer, we can’t treat it’ [PF14:35].
Diagnosis disclosure
Participant’s recounts of the time when they were told
that they had PAH described a mix of emotions: ‘a whirl;
good and bad’ [PF11:20]. Some patients described
inappropriate disclosure from non-medical staff: ‘I knew
something was wrong because she was shouting for the
cardiologist to come and look at the echo. I was lying
there thinking; something’s not right here and that is
when the panic set in’ [PF19:34]. Another was told by
a social worker that she ‘had an inoperable condition
and that I now needed to consider myself as disabled. I
just cried. I was distraught’ [PF2:56].
Disclosure by some medical professionals was also
viewed as lacking empathy. One explained that she was
told ‘you’ve got this, it’s worse than cancer, we can’t treat
it, can’t have a heart-lung transplant, we need to cut half
your heart and we’re going to do that on Monday .
that’s when I nearly died’ [PF14:35]. More positive
experiences were relayed when the team disclosing the
diagnosis acknowledged previous limitations: ‘they
[medical team] were terribly apologetic and said, we
never dreamt it was this and we are so sorry that it’s taken
us so long to get this far’, although gaps remained ‘they
didn’t know why I had it . what had caused it at the
time’ [PF2:56].
Making sense of the diagnosis
The diagnosis of PAH evoked a range of emotions, and
for most participants, it was the ﬁrst time they had heard
of the condition. There was a mix of ‘feeling relief but
scared’ [PM3:47]. For some, there was relief that the
diagnosis was not psychosomatic: ‘before, everybody
thought it was because of the depression’ [PM10:61].
Predominately, participants felt ill informed about
their condition and many turned to the internet as
a source of information gathering, often with devastating
Box 2 Examples of triggers for seeking medical advice
Patient’s self-recognition of trigger
- ‘I started blacking out. That’s when I went to see the
doctor. I thought maybe I was diabetic’ [PF14:35].
- ‘I walked up a short ladder and suddenly felt breathless-
ness. I thought . what’s going on now’ [PM25:54].
Family/friend recognition of trigger
- ‘He [partner] thought I was being attacked [while talking
on the phone] . I was so out of breath’ [PF19:34].
- ‘I met a girl that used to be a nurse [in the street] . I
stopped, I could not even speak to her . she says to me
what’s wrong with you you’re not well . I says I haven’t
a breath . she says . you shouldn’t be like that .’
[PF20:75].
- ‘I came home for the summer. My mum’s a nurse, so it
was when she started noticing that I couldn’t walk, never
mind breathe . so she sent me to the doctors’
[PF29:26].
- ‘Everyone thought I was pregnant because I was putting
on lots of weight . my mum picked me up after my shift,
and I told her that my feet had swollen up, so she said,
‘Well see if they go down, if they haven’t I’ll take you to
the hospital later.’ Everything below my knees was huge,
they’d gone like tree trunks. So she took me straight to
the hospital’ [PF19:34].
Box 3 Examples of misdiagnosis
- ‘I was given an inhaler. It made no difference whatsoever
and after a few months he [GP] thought it might be
stress, panic attacks . so prescribed [anxiolytic] . but it
didn’t do anything for my breathlessness’ [PM11:63].
- ‘They [GP] thought it was antiphospholipid syndrome for
quite a while and lupus, but none of the tests came back
positive’ [PM25:54].
- ‘All of this time I was getting more and more asthma
medication’ [PF29:26].
- ‘They [patient’s history presented at a case-conference]
thought it might be the pill’ [PF29:26].
- ‘He [respiratory specialist] twigged straight away that I
can’t just have asthma. So this was going on for six
years’ [PM12:31].
- ‘I just wanted answersdit was getting ridiculous’
[PM08:70].
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had died from it’ [PF29:26] and ‘you’re only going to
live 2 years’ [PF2:56; PF6:69; PF29:26]. However, reas-
surance was provided during the initial visits at PAH
specialist centres where most felt that they were
informed of what PAH is and what treatment options are
available (see box 4 for examples).
Resentment and anger became evident when partici-
pants reﬂected on the extended time that it took for
a deﬁnitive diagnosis (ﬁgures 1 and 2) and whether ‘if
I’d been diagnosed earlier perhaps I wouldn’t have been
so bad’ [PF21:65]. It was suggested that ‘that was the
whole problem, it had gone on so long’ [PF23:72].
Although it was acknowledged that PAH cannot be
tested for per sed‘they can only eliminate everything
else and then it’s got to be PAH’ [PM25:54].
DISCUSSION
Summary of main ﬁndings
To our knowledge, this is the ﬁrst report of the patient’s
trajectory to receiving a conﬁrmed diagnosis of PAH. In
this study, a lack of awareness of this illness from both
the sufferer themselves and the medical profession
emerged as a central theme of the trajectory to
a conﬁrmed diagnosis. People appeared to attempt to
make sense of unexplained breathlessness through
rationalising of potential reasons until a signiﬁcant event
triggered consultation with a medical professional.
Participants recounted a serious decline in their health
followed by a dramatic event such as collapsing in the
street or family members pleading with them to seek
medical advice. What followed was an extended period
of contact with few answers, while the condition
continued to deteriorate. This made family and work life
difﬁcult, and conﬂict was often described as having
taken place in the workplace as a result. Asthma was
a common misdiagnosis, and participants underwent
several tests at their local hospital but PAH was not
suspected at the time. Diagnosis disclosure was mostly
viewed by participants as lacking in sensitivity. The
protracted journey left some with a sense of anger and
wondering if an expedited diagnosis may have improved
their response to treatment and prognosis. Internet
searching for information related to PAH increased
anxiety and uncertainty which was only eased when
under the care of a specialist centre.
Meaning and implications
The data presented here elucidate the reasons why some
people with PAH experience delays in obtaining a diag-
nosis of PAH. The pre-diagnostic phase is punctuation by
transitional stages that are reﬂected in Anderson’s
model of total patient delay.
10 Participants described
a period of time where symptoms were apparent, in
particular breathlessness, but a range of self-explanations
were suggested such as increasing age and poor level
of ﬁtness. These patient-attributed delays are similar to
those found with the insidious onset of other long-term
conditions, notably chronic obstructive pulmonary
disease.
19 20 However, unlike chronic obstructive
pulmonary disease, which has been described as ‘a story
with no beginning’
19 PAH patients could vividly recall
the onset of symptoms. It is difﬁcult to make direct
comparisons with other conditions that present with
salient symptoms and misdiagnosis because PAH affects
a wide range of ages. In our study, the age of participants
ranged from 26 to 80 years. We opted to include
such a wide age group due to the dearth of research
relating to the experiences of people living with this
rare disease. We found that the pre-diagnostic experi-
ence of patients, including symptom interpretation and
responses from healthcare professionals, differed
according to age.
Participants in this study were found to have experi-
enced signiﬁcant illness and behavioural delay (stages 2
and 3 of Anderson’s model). The delay was apparent
regardless as to the age of the individual. Younger and
older participants described knowing that something was
wrong but ‘illness delay’ as a result of their own
perceptions continued until experiencing a critical event
or making a medical appointment at the insistence of
a family member or friend. It is likely that participants in
this study did not perceive the symptoms of PAH as
serious and were not aware of the potential conse-
quences of delaying medical opinion.
Overreliance on the internet may have prolonged
‘total patient delay’. In an attempt to cope with uncer-
tainty, participants in our study were inclined to search
the internet for answers including self-diagnosis and
trying to understand the diagnosis of PAH. Information
seeking by people diagnosed with PAH is related to
uncertainty about prognosis and limited knowledge of
the condition.
2 With diffusion and popularity of the
internet in recent years, it is inevitable that many people
will use this mode of communication as a source of
health-related information gathering.
21 22 In our study,
people were often misinformed because there was over-
reliance on personal accounts of patients or family
members living with PAHdwhere accounts included
Box 4 Examples of making sense of the diagnosisd
specialist pulmonary arterial hypertension contact
- ‘. people were doing things, explained what different
tests actually meant . drugs explained, right at the start
in the hospital’ [PF13:65].
- ‘We were told there were lots of medications these days
that could help and people were doing quite well on them.
It wasn’t as devastatingly unhopeful as ﬁrst appeared on
the internet’ [PF2:56].
- ‘I felt better because they told me what was up’ [P3M:47].
- ‘They understood . it was like, ﬁnally you get what I’m
going through . could explain all the hard ques-
tionsd‘It’s not a death sentence, there’s numbers of
reasons why you could have it . stay here and we’ll ﬁnd
out why and we’ll put you on the best treatment’
[PF29:26].
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tivesdrather than accessing more reputable sites (eg,
the Pulmonary Hypertension Association UK and British
Lung Foundation).
Anderson’s model has been previously expanded to
include healthcare professional delay in relation to
obtaining a diagnosis of ovarian cancer
11 and, as illus-
trated in this study, is also relevant to PAH. In the
context of conditions such as ovarian cancer, delay by
patients accounts for most of the delay experienced.
11
However, our study suggests that professional
delaydmisdiagnosis, a battery of tests and referrals to
different specialistsdis signiﬁcant and requires further
investigation and attention. PAH is a diagnosis of
exclusion
7; consequently, delays attributed to the patient
are often compounded by medical professional’s delays
because PAH is so difﬁcult to diagnose. The vagueness
and non-speciﬁcity of PAH symptoms challenge GPs,
who may see only one PAH patient in their entire career.
Patients present with a variety of symptoms, all of which
could be caused by common pulmonary conditions.
Since the symptoms are non-speciﬁc, the initial evalua-
tion of patients with these symptoms is often appropri-
ately directed at diagnosing or excluding more common
conditions. In the absence of an identiﬁable explana-
tion, however, pulmonary vascular disease should be
considered as a possible cause for these symptoms,
particularly unexplained dyspnoea.
In the UK, people who are suspected of having cancer,
including cancer of the lung, can expect to see
a specialist within 2 weeks.
23 No national guidelines exist
for unexplained dyspnoea where cancer is not
suspected. Guidelines and consensus statements exist for
the assessment and management of dyspnoea associated
with diagnosed respiratory or cardiac conditions but
these do not address the assessment of dyspnoea of
unknown cause.
24 25 A diagnostic pathway for unex-
plained dyspnoea may assist GPs and other healthcare
professionals to increase initial suspicion that less known
conditions, such as PAH, may be present and require
speciﬁc investigative testing. Active follow-up by GPs of
all patients with uncertain diagnoses is unrealistic when
NHS resources are stretched, but individuals should be
encouraged to return to their GP if their symptoms
persist
11 and not made to feel like they are ‘bothering’
the doctor. Speciﬁcally, setting a time limit for the follow-
up of people should leave no doubt about how long
dyspnoea should go unchecked.
Most participants described encounters with health
professionals that were perceived as lacking in empathy.
However, breaking bad news is also a complex commu-
nication task. Bad news often must be delivered in
settings that are not conducive to such intimate conver-
sations. The hectic pace of clinical practice may result in
a health professional delivering bad news with little
forewarning or when other responsibilities are com-
peting for attention. The complexity of the interaction
can sometimes create serious miscommunications such as
patient misunderstanding about the prognosis of the
illness or purpose of care.
26 Poor communication is
associated with reduced patient satisfaction.
27 28 In the
particular context of diagnostic and prognostic informa-
tion, the crucial role of communication in ‘breaking bad
news’ can have a signiﬁcant negative inﬂuence on the
patient’s psychosocial experience, symptom manage-
ment, treatment decisions and quality of life.
14 28e30
Regardless as to the amount of time that had past,
participants’ pictorial representations of their PAH
journey were largely focused on the pre-diagnostic
period which included the use of stimulus materials that
consisted of negative emotional connotations (eg, anger
and frustration). One participant who expressed a posi-
tive experience both pre-diagnosis and post-diagnosis
described how the medical team offered an apology for
not diagnosing PAH early. These results suggest that the
pre-diagnostic journey can have long-lasting effects on
the individual with PAH and should form part of the
patient’s care pathway following referral to the specialist
PAH centre. Referral to the specialist centre eased
patients’ uncertainty as questions were answered, and for
most participants, there was a sense of relief that, despite
initial perceptions, viable treatments for PAH were
available. There are nine specialist pulmonary hyper-
tension centres in the UK and Ireland which look after
people with PAH. Specialists’ centres adhere to inter-
national guidelines for the diagnosis and management
of PAH.
7 31 Participants in our study expressed concern
about the length of time that it took to be referred to
a specialists’ centre; many believed that if they had been
referred earlier, they would not have become so sick and
would have a better response to treatment.
STRENGTHS AND LIMITATIONS OF THIS STUDY
This qualitative study aimed for a maximum variation
sample and ‘in-depth’ description of diagnosis delay. As
such, we included patients with a wide range of back-
grounds and experiences and variation in length of time
since being diagnosed with PAH and not just those who
had particular concerns about diagnostic delay. We
believe we have identiﬁed a wider range of diagnostic
delays attributable to both the patient and healthcare
professionals. Given the role that the medical profes-
sion play in the patients’ trajectory to PAH diagnosis,
the exclusion of their views represents a limitation to
the current study. Living with a life-limiting condition
can present many challenges and life stressors; there-
fore, caution is required in interpreting retrospective
narrative interviews of an individual’s illness trajectory.
The data rely on patient’s recall of events and their
accounts of the pre-diagnostic phase involved. These
accounts may beneﬁt from hindsight and may or may
not accurately reﬂect what really happened. Participants
in our study ranged from <1y e a rt om o r et h a n1 0y e a r s
since diagnosis conﬁrmation. It could be argued that
the health service had changed during this time;
however, we found that participants’ reﬂections were
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The trajectory to diagnosis with pulmonary hypertensionsimilar and told in a vivid way despite the amount of
time that had lapsed. Nonetheless, the stories told in
this study reﬂect patients’ current views and therefore
provides a unique insight into people’s perceptions and
understandings of their experience and the meanings
they attach to it.
CONCLUSIONS
Limited awareness of PAH outside specialist centres
leads to misdiagnosis, delays in treatment and an
increasing sense of anger, frustration and confusion for
many patients. Repeated tests and visits to numerous
medical professionals, including GPs and cardiac or
respiratory consultants over a number of years, repre-
sents a signiﬁcant use of resources and consequent cost
to the NHS. National guidelines for the assessment and
diagnostic pathway of unexplained dyspnoea are
recommended.
Our results emphasise the importance of increasing
awareness of this disease in order to expedite the process
of correct diagnosis and the referral of patients with PAH
to specialised centres. Voluntary organisations may wish
to promote awareness of PAH and populate stories that
represent the wide range of people that it can affect to
aid both public and healthcare professional under-
standing of this life-limiting serious disease.
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